ArticleJournal of nanobiotechnology2025

An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma.

Meifang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.